3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells

Brain Research

Volumn 868, Issue 2, 2000, Pages 191-201

  Lamensdorf, Itschak ^a   Eisenhofer, Graeme ^a   Harvey White, Judith ^a   Nechustan, Amotz ^a   Kirk, Kenneth ^b   Kopin, irwan ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Complex I; Dihydroxyphenylacetaldehyde; Dihydroxyphenylacetic acid; Dihydroxyphenylethanol; Dopamine; MPP1; Parkinson sdisease; Rotenone

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ACETALDEHYDE; ALDEHYDE DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING); CLORGYLINE; DOPAMINE; DOPAMINE DERIVATIVE; IMIRESTAT; ROTENONE;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; METABOLITE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REDUCTION; TOXICITY;

1-METHYL-4-PHENYLPYRIDINIUM; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTIOXIDANTS; DOPAMINE; ENERGY METABOLISM; ENZYME INHIBITORS; ESTROGENS, NON-STEROIDAL; FLUORENES; HYDANTOINS; ISOFLAVONES; MITOCHONDRIA; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARKINSON DISEASE; PC12 CELLS; PHENYLETHYL ALCOHOL; RATS; ROTENONE;

EID: 0034705724     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02309-X     Document Type: Article

References (30)

1. Y. Ban T. Oishi The preparation of 2-(substituted phenyl)ethanols Chem. Pharm. Bull. 6 1958 574 576
2. P.G. Baraldi D. Simoni S. Manfredini E. Menzaiani Preparation of 3,4-dihydroxy-1-benzenethanol: a reinvestigation Liebigs Ann. Chem. 4 1983 684 686
3. A.N. Basma R.E. Heikkila M.S. Saporito M. Philbert H.M. Geller W.J. Nicklas 1-Methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysis J. Neurochem. 58 1992 1052 1059
4. W.J. Burke C.A. Schmitt K.N. Gillespie S.W. Li Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells Brain Res. 722 1996 232 235
5. W.J. Burke S.W. Li S. Zahm B.S. Kristal Neurotoxicity of DOPAL, the MAO metabolite of dopamine: Implications for Parkinson’s disease Neurology 52 1999 A345–A345
6. +2 fluxes and neurotoxicity in rat cerebellar granule cells Brain Res. 779 1998 194 204
7. A.M. Cesura A. Pletscher The new generation of monoamine oxidase inhibitors Prog. Drug Res. 38 1992 171 297
8. G. Eisenhofer I. Lamensdorf K.K. Kirk M. Kawamura S. Sato Oxidative deamination of monoamines and biogenic aldehydes in neurodegeneration C.R. Creveling Role of Catechol Quinone Species in Cellular Toxicity 2000 F.P. Graham Johnson City, TN 203 231
9. M. Gerlach P. Riederer H. Przuntek M.B. Youdim MPTP mechanisms of neurotoxicity and their implications for Parkinson’s disease Eur. J. Pharmacol. 208 1991 273 286
10. M. Kawamura I.J. Kopin P.F. Kador S. Sato O. Tjurmina G. Eisenhofer Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine J. Auton. Nerv. Syst. 66 1997 145 148
11. W.M. Keung B.L. Vallee Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria Proc. Natl. Acad. Sci. USA 95 1998 2198 21203
12. I. Lamensdorf N. Meiri J. Harvey-White D.M. Jacobowitz I.J. Kopin Kir6.2 oligoantisense administered into the globus pallidus reduces apomorphine-induced turning in 6-OHDA hemiparkinsonian rats Brain Res. 818 1999 275 284
13. I. Lamensdorf G. Eisenhofer J. Harvey-White Y. Hayakawa K. Kirk I.J. Kopin Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde J. Neurosci. Res. 60 2000 552 558
14. C. Manna P. Galletti V. Cucciolla O. Moltedo A. Leone V. Zappia The protective effect of the olive oil polyphenol (3,4-dihydroxyphenyl)-ethanol counteracts reactive oxygen metabolite-induced cytotoxicity in Caco-2 cells J. Nutr. 127 1997 286 292
15. M.B. Mattammal J.H. Haring H.D. Chung G. Raghu R. Strong An endogenous dopaminergic neurotoxin: implication for Parkinson’s disease Neurodegeneration 4 1995 271 281
16. B.A. McLaughlin D. Nelson M. Erecinska M.F. Chesselet Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor J. Neurochem. 70 1998 2406 2415
17. Y. Mizuno H. Yoshino S. Ikebe N. Hattori T. Kobayashi S. Shimoda-Matsubayashi H. Matsumine T. Kondo Mitochondrial dysfunction in Parkinson’s disease Ann. Neurol. 44 1998 S99 S109
18. A. Novelli J.A. Reilly P.G. Lysko R.C. Henneberry Glutamate becomes neurotoxic via the N -methyl- d -aspartate receptor when intracellular energy levels are reduced Brain Res. 451 1988 205 212
19. C.W. Olanow W.G. Tatton Etiology and pathogenesis of Parkinson’s disease Annu. Rev. Neurosci. 22 1999 123 144
20. +) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a microdialysis technique J. Neural. Transm. 70 1987 241 250
21. C. Pereira M.S. Santos C. Oliveria Metabolic inhibition increases glutamate susceptibility on a PC12 cell line J. Neurosci. Res. 51 1998 360 370
22. J.F. Reinhard Jr S.W. Carmichael A.J. Daniels Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures J. Neurochem. 55 1990 311 320
23. B.H. Robinson Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect Biochim. Biophys. Acta 1364 1998 271 286
24. A.H. Schapira Human complex I defects in neurodegenerative diseases Biochim. Biophys. Acta 1364 1998 261 270
25. C. Schöpf E. Brass E. Jacobi W. Jorde W. Mocnik L. Neuroth W. Salzer Die synthese des 3-oxo-4-methoxy-phenylacetaldehyde (Homoisovanillins) und des 3,4-Dioxy-phenylacetaldehydes (Homoprotocatechualdehyde) Liebigs. Ann. Chem. 544 1940 30
26. T.A. Seaton J.M. Cooper A.H. Schapira Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors Brain Res. 777 1997 110 118
27. M.S. Shearman C.I. Ragan L. Iversen Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death Proc. Natl. Acad. Sci. USA 91 1994 1470 1474
28. T.P. Singer J.I. Salach D. Crabtree Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Biochem. Biophys. Res. Commun. 127 1985 707 712
29. H. Takamidoh M. Naoi T. Nagatsu Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine Neurosci. Lett. 73 1987 293 297
30. H. Weiner X. Wang Aldehyde dehydrogenase and acetaldehyde metabolism Alcohol Alcohol. Suppl. 2 1994 S141 S145